Angioimmunoblastic T-cell lymphoma (AITL) is a rare type of non-Hodgkin lymphoma typically occurring in older adults. While it can affect people of all ages, it is most often diagnosed in individuals between the ages of 60-70. In rare cases, it can affect people in their 40s or 50s.
AITL typically presents itself as enlarged lymph nodes in the neck, armpits, and groin areas, as well as fever, night sweats, skin rashes, and weight loss. Other symptoms can include enlarged spleen or liver, swollen legs or arms, and fatigue. If the cancer spreads to other organs, such as the liver, lungs, or bone marrow, it can lead to other symptoms, such as shortness of breath, abdominal pain, or anemia.
Treatment for AITL usually involves a combination of chemotherapy, radiation therapy, and/or stem cell transplantation. The goal of treatment is to control the disease and stop it from spreading. Depending on the individual’s health and the stage of the cancer, doctors may also recommend surgery to remove affected lymph nodes or organs.
Due to its rarity, there is no standard treatment for AITL and outcomes can vary widely. It is important to speak with a healthcare professional to determine the best course of action for an individual’s case.